Cleared Traditional

K060648 - REPROCESSED PHACOEMULSIFICATION TIPS

K060648 is an FDA 510(k) clearance for REPROCESSED PHACOEMULSIFICATION TIPS, manufactured by Alliance Medical Corp.. The device is a Class 2 Ophthalmic device with product code NKX cleared through the Traditional 510(k) pathway after a 371-day FDA review.

K060648 · Alliance Medical Corp. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2007
Decision
371d
Days
Class 2
Risk

K060648 is an FDA 510(k) clearance for the REPROCESSED PHACOEMULSIFICATION TIPS. Classified as Needle, Phacoemulsification, Reprocessed (product code NKX), Class II - Special Controls.

Submitted by Alliance Medical Corp. (Phoenix, US). The FDA issued a Cleared decision on March 19, 2007 after a review of 371 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Alliance Medical Corp. devices

FDA 510(k) Submission Details - K060648

510(k) Number K060648 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2006
Decision Date March 19, 2007
Days to Decision 371 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
261d slower than avg
Panel avg: 110d · This submission: 371d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NKX Device Classification - Class 2, Special Controls

Product Code NKX Needle, Phacoemulsification, Reprocessed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
Definition Needle For Phacoemulsification Device To Remove Cataractous Lens. Same As Needle For Main Phacoemulsification Device And Un-reprocessed Needle With Product Code Hqc, Except This Is A "reprocessed" Needle. The Phacoemulsification Device Is Not Reprocessed, Just The Needle. Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission. (70 Fr 56911, Available At Https://www.govinfo.gov/content/pkg/fr-2005-09-29/pdf/05-19510.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.